2013
DOI: 10.1590/1516-4446-2012-0860
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: Objective: To present the most relevant findings regarding the Brazilian Medical Association guidelines for the diagnosis and differential diagnosis of panic disorder. Methods: We used the methodology proposed by the Brazilian Medical Association for the Diretrizes Project. The MEDLINE (PubMed), Scopus, Web of Science, and LILACS online databases were queried for articles published from 1980 to 2012. Searchable questions were structured using the PICO format (acronym for ''patient'' [or population], ''interven… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 96 publications
0
1
0
Order By: Relevance
“…A prerequisite for conducting these clinical trials and mechanistic studies is an international consensus on the definition of TR‐AD, which is currently lacking 17,26 . International guidelines focusing on anxiety disorders do not provide explicit criteria aiding in the identification or treatment of patients with TR‐AD 15,27‐50 , with only two exceptions. First, the Canadian Clinical Practice Guidelines for the Management of Anxiety Disorders 51 suggest that patients who “do not respond to first‐ or second‐line agents” (in panic disorder), who “do not respond to several medication trials and/or CBT” (in social anxiety disorder), or who “do not respond to multiple courses of therapy” (in GAD) should be considered treatment‐refractory.…”
mentioning
confidence: 99%
“…A prerequisite for conducting these clinical trials and mechanistic studies is an international consensus on the definition of TR‐AD, which is currently lacking 17,26 . International guidelines focusing on anxiety disorders do not provide explicit criteria aiding in the identification or treatment of patients with TR‐AD 15,27‐50 , with only two exceptions. First, the Canadian Clinical Practice Guidelines for the Management of Anxiety Disorders 51 suggest that patients who “do not respond to first‐ or second‐line agents” (in panic disorder), who “do not respond to several medication trials and/or CBT” (in social anxiety disorder), or who “do not respond to multiple courses of therapy” (in GAD) should be considered treatment‐refractory.…”
mentioning
confidence: 99%